Conclusion
The outcomes of EVAR patient in the current study demonstrates safety and acceptable durability of the endografts at AAA patients at five years with survival rate over 60% and freedom from secondary intervention exceeding 80%. Large aneurysms, low ejection fraction, poor renal function and anemia are independent predictors of reduced survival after endovascular repair of aneurysm. Longer-term follow-up is expected to be reported through 10-years.